IX. Body Growth, Muscle Strength, and Serum Solutes During Methyltestosterone-KCl Therapy

5-8 of such agents and the recognized variability in the rate of physical deterioration in this condition which might mask less dramatic though nonetheless beneficial effects. It was felt that such trials would necessitate pharmacologic dosages of an androgenic steroid, since no evidence of a deficiency of endogenous androgens in childhood or juvenile muscular dystrophy has appeared to date. It is well recognized, of course, that disturbances of gonadal and adrenocortical steroid production and other endocrinopathy may be a frequent feature of another form of muscular dystrophy, i. e., in dystrophia myotonica or Steinert's disease.9,10